SOLENO THERAPEUT. DL-001 (6XC) — Strategic Asset Allocation Index
SOLENO THERAPEUT. DL-001 (6XC) has a Strategic Asset Allocation Index of 44.6% as of December 2025. Strategic assets (PP&E of €- plus long-term investments of €200.62 Million) total €200.62 Million, measured against net assets of €450.12 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See SOLENO THERAPEUT. DL-001 (6XC) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
SOLENO THERAPEUT. DL-001 Strategic Asset Allocation Index (2023–2025)
This chart shows how SOLENO THERAPEUT. DL-001's Strategic Asset Allocation Index has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the index stands at 44.6%, representing strategic assets of €200.62 Million against net assets of €450.12 Million EUR. For live market cap and overall valuation, see 6XC market cap.
Annual Strategic Asset Allocation Index for SOLENO THERAPEUT. DL-001 (2023–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for SOLENO THERAPEUT. DL-001 from 2023 to 2025, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See SOLENO THERAPEUT. DL-001 (6XC) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 44.6% | €200.62 Million | €- | €200.62 Million | €450.12 Million | ▲ +33.5 pp |
| 2024 | 11.1% | €27.21 Million | €- | €27.21 Million | €245.11 Million | ▲ +11.1 pp |
| 2023 | 0.0% | €0.00 | €- | €0.00 | €157.51 Million | — |